Alpha-fetoprotein (AFP), a secreted 70 kD glycoprotein, has been used as a biomarker for HCC as elevated expression of AFP in tumors and serum is found in 60–80% of HCC patients and correlates with poor prognosis (13). This evidence concerns the gene AFP and hepatocellular carcinoma.